2m 2m 2m 2m 2m 2m 2m
Talphera (TLPH)
NASDAQ
$0.80+$0.02 (+2.80%)
Price as of Jun 03, 2026 6:22 PM EDT- $42.4MMarket Cap
- 62.84%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Talphera (TLPH)
$0.80+$0.02 (+2.80%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 28,000 N/A | 0 -100.00% | 651,000 -63.24% | 1.8M -37.15% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 2.6M -30.96% | |
Gross Profit | 28,000 N/A | 0 -100.00% | 651,000 +179.39% | -820,000 -12.30% | |
Sales and Marketing Expense | 7.5M -12.36% | 8.5M -28.85% | 12.0M -53.28% | 25.7M -17.01% | |
Research and Development Expense | -6.0M -10.20% | -6.7M +21.13% | -5.5M +6.80% | -5.2M +26.81% | |
Depreciation and Amortization Expense | N/A N/A | 0 -100.00% | 311,000 -81.12% | 1.6M -16.52% | |
Total Operating Expenses | 13.5M -11.41% | 15.3M -13.04% | 17.5M -54.33% | 38.4M -0.98% | |
Operating Profit | -13.5M -11.59% | -15.3M -9.69% | -16.9M -53.90% | -36.6M +1.86% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -100,000 -25.37% | -134,000 -88.38% | -1.2M -49.67% | |
Interest Income and Expense and Net | 0 +100.00% | -100,000 -25.37% | -134,000 -88.38% | -1.2M -49.67% | |
Total Nonoperating Income and Expense | -879,000 -139.10% | 2.2M -65.95% | 6.6M -92.18% | 84.4M +9,590.13% | |
Income before Taxes | -13.5M -11.59% | -15.3M +48.26% | -10.3M -121.54% | 47.8M +236.11% | |
Income Taxes | 0 N/A | 0 N/A | 0 -100.00% | 13,000 +160.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -14.3M +9.89% | -13.0M -29.31% | -18.4M -138.52% | 47.8M +236.06% | |
Net Income from Continuing Operations Applicable to Common | -14.4M +10.45% | -13.0M +26.41% | -10.3M -124.30% | 42.3M +220.65% | |
Basic EPS and Net Income | -0.34 -32.00% | -0.50 -61.24% | -1.29 -122.51% | 5.73 +2,075.86% | |
Diluted EPS and Net Income | -0.34 -32.00% | -0.50 -61.24% | -1.29 -122.55% | 5.72 +2,072.41% | |
Basic Weighted Average Shares | 42.4M +64.09% | 25.8M +81.20% | 14.3M +93.14% | 7.4M -93.84% | |
Diluted Weighted Average Shares | 42.4M +64.09% | 25.8M +81.20% | 14.3M +92.57% | 7.4M -93.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.9M -33.50% | 8.9M +54.92% | 5.7M -62.55% | 15.3M +20.63% | |
Short-Term Investments | 14.5M N/A | 0 -100.00% | 3.7M +639.39% | 495,000 -98.73% | |
Cash and Cash Equivalents and Short-Term Investments | 20.4M +129.96% | 8.9M -5.52% | 9.4M -40.51% | 15.8M -69.46% | |
Total Current Assets | 20.9M +121.94% | 9.4M -18.51% | 11.6M -52.96% | 24.6M -55.73% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | 11.6M +7.48% | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 10.3M -35.58% | |
Total Long-Term Assets | N/A N/A | N/A N/A | 20,000 -91.87% | 246,000 -88.68% | |
Total Assets | 29.7M +62.97% | 18.2M -10.59% | 20.4M -57.05% | 47.5M -39.04% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 5.8M -34.48% | |
Total Current Liabilities | 3.8M +43.90% | 2.6M -41.33% | 4.5M -67.23% | 13.8M -25.60% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 5.4M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 2.4M +123.94% | 1.1M N/A | 0 -100.00% | 810,000 +900.00% | |
Total Liabilities | 12.7M +23.93% | 10.2M +62.72% | 6.3M -75.50% | 25.7M -77.44% | |
Retained Earnings | -471.5M +3.13% | -457.2M +2.93% | -444.2M +4.32% | -425.8M -10.08% | |
Total Stockholders Equity | 17.0M +112.91% | 8.0M -43.28% | 14.1M -35.34% | 21.8M +160.78% | |
Total Shares Outstanding | 49.3M +189.66% | 17.0M +0.45% | 17.0M +105.64% | 8.2M -93.97% | |
Cash Flow | |||||
Cash from Operating Activities | -11.4M -10.40% | -12.7M -27.49% | -17.5M -38.26% | -28.3M -5.57% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 100,000 -72.53% | 364,000 -80.08% | |
Cash from Investing Activities | -14.3M -479.40% | 3.8M +816.10% | -528,000 -101.45% | 36.5M +239.53% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 22.7M +88.81% | 12.0M +247.49% | 3.5M +783.63% | -507,000 -101.22% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | -46.30% +39.55% | |
Operating Margin | -48,157.14% N/A | N/A N/A | -2,594.32% +25.42% | -2,068.49% +62.07% | |
Return on Assets | -59.60% -11.48% | -67.32% +24.21% | -54.20% -171.15% | 76.18% +256.47% | |
Return on Equity | -114.16% -2.97% | -117.65% +14.85% | -102.44% -84.90% | -678.39% -985.63% | |
Revenue Growth | N/A N/A | -100.00% +58.13% | -63.24% +70.21% | -37.15% -22.55% | |
Current Ratio | 5.49 +54.23% | 3.56 +38.90% | 2.56 +43.57% | 1.78 -40.49% | |
Cash Ratio | 1.55 -53.79% | 3.35 +164.06% | 1.27 +14.31% | 1.11 +62.13% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.38 +44.89% | 0.26 +168.69% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.26 +118.12% | 0.12 -31.49% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow